{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:51:50Z","timestamp":1790693510526,"version":"4.1.0"},"reference-count":35,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,7,18]],"date-time":"2008-07-18T00:00:00Z","timestamp":1216339200000},"content-version":"vor","delay-in-days":2755,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Eur J of Neuroscience"],"published-print":{"date-parts":[[2001,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The search for new ocular hypotensive agents represents a frontier of current eye research because blindness due to optic neuropathy occurs insidiously in 10% of all patients affected by glaucoma. Cannabinoids have been proposed to lower intraocular pressure by either central or peripheral effects but a specific mechanism for this action has never been elucidated. We recently demonstrated the presence of the central cannabinoid receptor (CB<jats:sub>1<\/jats:sub>) mRNA and protein in the human ciliary body. In the present study we show that the synthetic CB<jats:sub>1<\/jats:sub> receptor agonist, WIN 55212\u20132, applied topically at doses of 25 or 50\u2003\u00b5g (<jats:italic>n<\/jats:italic>\u2003=\u20038), decreases the intraocular pressure of human glaucoma resistant to conventional therapies within the first 30\u2003min (15\u2003\u00b1\u20030.5% and 23\u2003\u00b1\u20030.9%, respectively). A maximal reduction of 20\u2003\u00b1\u20030.7% and 31\u2003\u00b1\u20030.6%, respectively, is reached in the first 60\u2003min. These data confirm that CB<jats:sub>1<\/jats:sub> receptors have direct involvement in the regulation of human intraocular pressure, and suggest that, among various classes of promising antiglaucoma agents, synthetic CB<jats:sub>1<\/jats:sub> receptor agonists should deserve further research and clinical development.<\/jats:p>","DOI":"10.1046\/j.0953-816x.2000.01401.x","type":"journal-article","created":{"date-parts":[[2003,3,6]],"date-time":"2003-03-06T14:36:58Z","timestamp":1046961418000},"page":"409-412","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":104,"title":["The synthetic cannabinoid WIN55212\u20102 decreases the intraocular pressure in human glaucoma resistant to conventional therapies"],"prefix":"10.1111","volume":"13","author":[{"given":"Anna","family":"Porcella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Maxia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Luigi","family":"Gessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Pani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,7,18]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1006\/exer.1996.0012"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199810293391808"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.35.22330"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(97)00348-5"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-60963-3_3"},{"key":"e_1_2_6_7_1","unstructured":"AndrewC.World Medical Assembly in Helsinki(1984)Declaration of Helsinki Adopted in 1964 by the 18th World Medical Assembly in Helsinki Finland and revised by the 29th World Medical Assembly in Tokyo in 1975. InVarga(ed) The Main Issue in Bioethics(Revised Edn).Paulist Press New York. pp.45\u201350."},{"key":"e_1_2_6_8_1","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/372686a0","article-title":"Formation and inactivation of endogenous cannabinoid anandamide in central neurons","volume":"372","author":"Di M.V.","year":"1994","journal-title":"Nature"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.3109\/02713688409000797"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1981.tb02627.x"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(95)00203-i"},{"key":"e_1_2_6_12_1","first-page":"102","article-title":"Interaction of adrenergic antagonists with prostaglandins E2 and tetrahydrocannabinol in the eye","volume":"15","author":"Green K.","year":"1976","journal-title":"Invest. Ophtalmol."},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1971.03190100074024"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1159\/000267984"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1997.01100150184006"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1006\/exer.1996.0265"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.1985.1.101"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0079-6468(08)70037-7"},{"key":"e_1_2_6_19_1","first-page":"715","article-title":"Glaucoma, hypertension, and marijuana","volume":"74","author":"Merritt J.C.","year":"1982","journal-title":"J. Natl Med. Assoc."},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(80)35258-5"},{"key":"e_1_2_6_21_1","first-page":"947","article-title":"Oral Delta (9) \u2010tetrahydrocannabinol, in heterogenous glaucoma","volume":"12","author":"Merritt J.C.","year":"1980","journal-title":"Ann. Ophthalmol."},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02246436"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(96)00169-5"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0024-3205(98)00499-8"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1159\/000057150"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0169-328x(98)00105-3"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.2000.01027.x"},{"key":"e_1_2_6_28_1","first-page":"921","article-title":"Delta (9) \u2010tetrahydrocannabinol, euphoria and intraocular pressure in man","volume":"7","author":"Purnell W.D.","year":"1975","journal-title":"Ann. Ophthalmol."},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.80.5.389"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-6147(97)01161-9"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/PL00005093"},{"key":"e_1_2_6_32_1","first-page":"136","article-title":"Involvement of cannabinoid receptors in the intraocular pressure\u2010 lowering effects of WIN55212\u20102","volume":"292","author":"Song Z.H.","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.25.14565"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm9608725"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1997.78.1.43"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/37371"}],"container-title":["European Journal of Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.0953-816X.2000.01401.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.0953-816X.2000.01401.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T08:34:01Z","timestamp":1696322041000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.0953-816X.2000.01401.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["10.1046\/j.0953-816X.2000.01401.x"],"URL":"https:\/\/doi.org\/10.1046\/j.0953-816x.2000.01401.x","archive":["Portico"],"relation":{},"ISSN":["0953-816X","1460-9568"],"issn-type":[{"value":"0953-816X","type":"print"},{"value":"1460-9568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1]]},"assertion":[{"value":"2008-07-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}